Startup profile for Fundly.ai: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Fundly.ai funding, valuation and investors

B2B pharma commerce, payments, and embedded credit for India’s retail and distributor supply chain.

Keep track of Fundly.ai

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Seed

$3M · 2023

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$3M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series a · Mumbai, India

Investors in latest funding

Lead: Accel

Other: Multiply Ventures

Latest tracked event: Equity + venture debt (September 2026). It is shown separately because it is not counted as disclosed equity funding.

Sources: latest funding Last verified: 2026-09-08

Overview

Mumbai-based Fundly.ai, founded in 2021 by Amit Chawla and Shreeram Ramanathan, started in pharma supply-chain financing and now combines B2B commerce, payments/settlement, and embedded credit for retailers and distributors. Indian Startup Times reported a September 8, 2026 financing of about $4 million equity led by existing investors Accel and Multiply Ventures, with former RBL Bank executive director Rajeev Ahuja and other angels, plus roughly $0.9 million venture debt (~$4.9 million combined). Prior Accel-led seed was $3 million in 2023.

Why Fundly.ai is interesting

September 8, 2026 ~$4M equity led by Accel and Multiply Ventures plus ~$0.9M venture debt (~$4.9M total) — Accel doubling down after a 2023 $3M seed as Fundly expands from supply-chain finance into full-stack pharma distribution rails.

Product & use cases

Digital procurement, settlement, and credit tools for pharma retailers and distributors that previously ran on fragmented financing and offline ordering.

  • Pharma retailer procurement and working-capital access
  • Distributor payments and settlement automation
  • Embedded credit against trade flows in the pharma supply chain

Key facts

  • ~$4M equity led by Accel + Multiply Ventures; ~$0.9M venture debt (~$4.9M total) — Sep 8, 2026
  • Builds on Accel-led $3M seed (2023)
  • Product stack: B2B commerce + payments + embedded working-capital credit for pharma retail/distribution

Funding history (newest first)

Equity + venture debt

2026-09 ~$4.9M ($4M equity + $0.9M debt)
  • Accel (lead)
  • Multiply Ventures (lead)
  • Rajeev Ahuja (participant)

Source: https://www.indianstartuptimes.com/investment/fundly-ai-raises-4-million-to-expand-b2b-pharma-distribution-platform/

Industries

Fintech Marketplaces Healthtech

Related funding articles

Venture Capital Tracker pieces that cover Fundly.ai's financing or category context.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.